Colpopexy and Urinary Reduction Efforts (CARE) Protocol (CARE)
Urinary Incontinence, Stress, Uterine Prolapse, Vaginal Prolapse
About this trial
This is an interventional prevention trial for Urinary Incontinence, Stress focused on measuring Urinary incontinence, Pelvic organ prolapse, Stress incontinence, Sacrocolpopexy, Burch urethropexy, Surgical Trials
Eligibility Criteria
Inclusion Criteria Eligibility for primary procedure (sacrocolpopexy) Eligibility for secondary procedure (Burch colposuspension) Stage II-IV anterior vaginal prolapse, defined as POP-Q Point Aa at -1, 0, +1, +2, or +3 cm. Negative stress incontinence screen Negative stress incontinence screen (MESA questionnaire) Exclusion Criteria Contraindication for sacrocolpopexy or Burch colposuspension. Anatomic contraindication for Burch colposuspension (i.e., Point Aa fixed at -2 or -3 cm). Surgeon judgment that a contraindication to Burch colposuspension exists. Anticipated geographic relocation within the first three months after surgery (e.g., within approximately 6 months of screening). Inability to provide informed consent or to complete testing or data collection. Currently pregnant.
Sites / Locations
- The University of Alabama at Birmingham
- Loyola University Medical Center
- University of Iowa College of Medicine
- Johns Hopkins School of Medicine
- University of North Carolina at Chapel Hill
- Magee-Womens Hospital
- Baylor College of Medicine
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Abdominal Sacral Colpopexy with no Burch colposuspension
Abdominal Sacral Colpopexy with Burch Colposuspension
Abdominal sacral colpopexy is performed through a laparotomy approach.
The Burch colposuspension procedure entails the retropubic placement of at least two stitches in the vaginal tissue lateral to each side of the urethra, and suspension of these stitches from Cooper's ligament (the iliopectineal line at the superior aspect of the posterior pubic bone).